Daily non-political popular news in brief.
New data show ACTOS(r) (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
11-13-2006 · EurekAlert!Researchers today presented data showing that ACTOS® (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid intima-media thickness (CIMT) in patients with type 2 diabetes. Results from the clinical trial, CHICAGO (Carotid intima-media tHICkness in Atherosclerosis using pioGlitazOne), are part of a late-breaker presentation at the American Heart Association's Scientific Sessions 2006, coincidentally being held in Chicago, and coincide with an early online issue of the Journal of the American Medical Association.
Read more »
Keywords: data, show, actos, pioglitazone, hcl, halted, progression, atherosclerosis, indicated, cimt, acto, atherosclerosi
« Previous | Next »
Similar news on "New data show ACTOS(r) (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT":
- New data show ACTOS (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
11-13-2006 · EurekAlert!
Researchers today presented data showing that ACTOS (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid intima-media thickness (CIMT) in patients with type 2 diabetes. Results from the clinical trial, CHICAGO (Carotid intima-media thickness in Atherosclerosis using pioglitazone), are part of a late-breaker presentation at the American Heart Association's Scientific Sessions 2006, coincidentally being held in Chicago, and coincide with an early online issue of the Journal of the American Medical Association.
Similar news · Read more »
- Combination HDL/LDL therapy has no effect on plaque build-up
03-26-2007 · EurekAlert!
Two RADIANCE studies presented today at the American College of Cardiology's 56th Annual Scientific Session assessed the effects of adding torcetrapib to atorvastatin among patients to improve their cholesterol levels. Although the ILLUMINATE study and other trials involving torcetrapib were recently stopped because of safety concerns, the effect of the drug on carotid intima-media thickness (CIMT) may provide useful information on whether it slows the progression of atherosclerosis.
Similar news · Read more »
- Global warming is reducing ocean life, increasing atmospheric carbon dioxide, say scientists
12-06-2006 · EurekAlert!
Alarming new satellite data show that the warming of the world's oceans is reducing ocean life while contributing to increased global warming.
Similar news · Read more »
- NASA data show earthquakes may quickly boost regional volcanoes
04-10-2007 · EurekAlert!
Scientists using NASA satellite data have found strong evidence that a major earthquake can lead to a nearly immediate increase in regional volcanic activity.
Similar news · Read more »
- New study reveals gender disparity in anti-TNF treatment for rheumatoid arthritis
06-14-2007 · EurekAlert!
Findings reported today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain, reveal a treatment disparity between female and male patients with rheumatoid arthritis. Data from a study at the Karolinska Institute, Sweden, show that women receive anti-TNFs -- very effective but expensive modern medications against this disease -- at a higher perceived level of disease activity, and when they are reporting more severe pain than their male counterparts.
Similar news · Read more »
- New research shows ACTOS is associated with a 38 percent lower risk of heart attack
09-19-2007 · EurekAlert!
New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes, further support the cardiovascular safety of ACTOS (pioglitazone HCI) and its benefits regarding improved blood glucose and blood lipid levels for patients with type 2 diabetes.
Similar news · Read more »
- Lewis and Clark data show narrower, more flood-prone river
11-13-2006 · EurekAlert!
A geologist at Washington University in St. Louis and his collaborator at Oxford University have interpreted data that Lewis and Clark collected during their famous expedition and found that the Missouri River has markedly narrowed and its water levels have become more variable over the past two hundred years. This narrowing, or channeling, has put the Missouri River at an increased risk of more damaging floods.
Similar news · Read more »
- IMS updated recommendations on postmenopausal hormone therapy
05-16-2007 · EurekAlert!
The Updated Recommendations express the views of the International Menopause Society on the principles of hormone therapy in the peri- and postmenopausal periods. New data and re-analyses of older studies by women's age show that, for most women, the potential benefits of hormone therapy given for a clear indication are many and the risks are few when initiated within a few years of menopause.
Similar news · Read more »
- New WHI data show that women aged 50-59 taking oral estrogen therapy had reduced levels
06-20-2007 · EurekAlert!
Wyeth Pharmaceuticals, a division of Wyeth, provides comment on the Women's Health Initiative Coronary Artery Calcium Study published today in the New England Journal of Medicine. The study found that younger menopausal women (aged 50-59) who received a standard dose of oral conjugated estrogens had significantly less coronary artery calcification at the end of the study period compared with those taking placebo.
Similar news · Read more »
- Study finds genetic influence on pace of HIV/AIDS progression
10-22-2007 · EurekAlert!
Viral load -- the amount of virus in the blood of an HIV-infected person -- has long been viewed as the chief indicator of how quickly someone infected with HIV infection progresses to AIDS. New data published in Nature Immunology builds on previous work that suggests that several other factors in addition to viral load significantly contribute to disease progression rates.
Similar news · Read more »
